Last Name

Harinarayanan Janakiraman

InstitutionMedical University of South Carolina
DepartmentSurgical Oncology
AddressP.O. Box MSC 509
Basic Science Building - 173 Ashley Ave.
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Janakiraman H, Zhu Y, Becker SA, Wang C, Cross A, Curl E, Lewin D, Hoffman BJ, Warren GW, Hill EG, Timmers C, Findlay VJ, Camp ER. Modeling rectal cancer to advance neoadjuvant precision therapy. Int J Cancer. 2020 Jan 27. PMID: 31989583.
      View in: PubMed
    2. House R, Majumder M, Janakiraman H, Ogretmen B, Kato M, Erkul E, Hill E, Atkinson C, Barth J, Day TA, Palanisamy V. Smoking-induced control of miR-133a-3p alters the expression of EGFR and HuR in HPV-infected oropharyngeal cancer. PLoS One. 2018; 13(10):e0205077. PMID: 30289952.
      View in: PubMed
    3. Gani L, Lau E, Luk A, Sobrepena L, Tran QK, Kesavadev J, Jia W, Yu W, Tsang CC, Mukhopadhyay M, Jha S, Sheu W, Ho YK, Nguyen TK, Ozaki R, So WY, Kwan C, Fu AWC, Mirasol R, Phatak SR, Kumar KMP, Aravind S, Janakiraman H, Chan JCN. Cross-sectional survey of biosimilar insulin utilization in Asia: The Joint Asia Diabetes Evaluation Program. J Diabetes Investig. 2018 Nov; 9(6):1312-1322. PMID: 29575724.
      View in: PubMed
    4. Janakiraman H, House RP, Gangaraju VK, Diehl JA, Howe PH, Palanisamy V. The Long (lncRNA) and Short (miRNA) of It: TGFß-Mediated Control of RNA-Binding Proteins and Noncoding RNAs. Mol Cancer Res. 2018 04; 16(4):567-579. PMID: 29555893.
      View in: PubMed
    5. Janakiraman H, House RP, Talwar S, Courtney SM, Hazard ES, Hardiman G, Mehrotra S, Howe PH, Gangaraju V, Palanisamy V. Repression of caspase-3 and RNA-binding protein HuR cleavage by cyclooxygenase-2 promotes drug resistance in oral squamous cell carcinoma. Oncogene. 2017 06 01; 36(22):3137-3148. PMID: 27941877.
      View in: PubMed
    6. Banerjee A, Thyagarajan K, Chatterjee S, Chakraborty P, Kesarwani P, Soloshchenko M, Al-Hommrani M, Andrijauskaite K, Moxley K, Janakiraman H, Scheffel MJ, Helke K, Armenson K, Palanisamy V, Rubinstein MP, Mayer EG, Cole DJ, Paulos CM, Nishimura MI, Mehrotra S. Lack of p53 Augments Antitumor Functions in Cytolytic T Cells. Cancer Res. 2016 09 15; 76(18):5229-5240. PMID: 27466285.
      View in: PubMed
    7. Janakiraman H, Nobukiyo A, Inoue H, Kanno M. Mel-18 controls the enrichment of tumor-initiating cells in SP fraction in mouse breast cancer. Hiroshima J Med Sci. 2011 Jun; 60(2):25-35. PMID: 21970185.
      View in: PubMed
    8. Janakiraman H, Abraham G, Matthew M, kuruvilla S, Panikar V, Solomon S, Seshan SV, Lesley N. Correlation of CD4 counts with renal disease in HIV positive patients. Saudi J Kidney Dis Transpl. 2008 Jul; 19(4):603-7. PMID: 18580020.
      View in: PubMed
    9. Kanno R, Janakiraman H, Kanno M. Epigenetic regulator polycomb group protein complexes control cell fate and cancer. Cancer Sci. 2008 Jun; 99(6):1077-84. PMID: 18422744.
      View in: PubMed
    10. Janakiraman H, Abraham G, Mathew M, Lalitha MK, Bhaskar S. Relapsing peritonitis due to co-infection with Mycobacterium triviale and Candida albicans in a CAPD patient. Perit Dial Int. 2007 May-Jun; 27(3):311-3. PMID: 17468481.
      View in: PubMed
    Janakiraman's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Co-Authors Expand Description
    Similar People Expand Description